Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
PCN Reports : Psychiatry and Clinical Neurosciences|October 24, 2025
Development and validation of the Delirium Burden Scale for Healthcare Providers (DBS-HCP)Naoya Ueda, Ichiro Tazaki, Michael LoPresti, et al.BMJ Open|December 15, 2022
Incremental medical cost of delirium in elderly patients with cognitive impairment: analysis of a nationwide administrative database in JapanMasakazu Igarashi, Kotoba Okuyama, Naoya Ueda, et al.BMJ Open|September 14, 2022
Demographic and clinical characteristics of patients with delirium: analysis of a nationwide Japanese medical databaseNaoya Ueda, Masakazu Igarashi, Kotoba Okuyama, et al.Bioorganic & Medicinal Chemistry Letters|July 1, 2009
Identification of MK-1925: a selective, orally active and brain-penetrable opioid receptor-like 1 (ORL1) antagonistKensuke Kobayashi, Tomohiro Tsujita, Hirokatsu Ito, et al.European Journal of Pharmacology|April 8, 2010
Effects of a novel metabotropic glutamate receptor 7 negative allosteric modulator, 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo[4,5-c]pyridin-4(5H)-one (MMPIP), on the central nervous system in rodentsHirohiko Hikichi, Takeshi Murai, Shoki Okuda, et al.Journal of Medicinal Chemistry|February 3, 2006
Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarityYasuhiro Goto, Sachie Arai-Otsuki, Yukari Tachibana, et al.Current Radiopharmaceuticals|December 31, 2016
Development of a Novel Carbon-11 Labeled PET Radioligand for Melanin- Concentrating Hormone Receptor 1Hideyuki Igawa, Vladimir Stepanov, Lenke Tari, et al.European Journal of Pharmacology|December 18, 2016
A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent modelsYayoi Kawata, Shoki Okuda, Natsu Hotta, et al.Bioorganic & Medicinal Chemistry|April 28, 2016
Amine-free melanin-concentrating hormone receptor 1 antagonists: Novel non-basic 1-(2H-indazole-5-yl)pyridin-2(1H)-one derivatives and mitigation of mutagenicity in Ames testHideyuki Igawa, Masashi Takahashi, Minoru Ikoma, et al.Endocrinology|March 22, 2017
A Selective Bombesin Receptor Subtype 3 Agonist Promotes Weight Loss in Male Diet-Induced-Obese Rats With Circadian Rhythm ChangeYasunori Nio, Natsu Hotta, Minoru Maruyama, et al.Pageof 3